Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mick J. Daniel"'
Publikováno v:
Clinical Pharmacokinetics. 36:41-50
The objective of this study was to assess the potential of zanamivir, a specific inhibitor of influenza A and B virus neuraminidase, to interact with other coadministered therapies in the clinical setting.Potential interactions with zanamivir were ex
Autor:
Andy J. Harker, Elizabeth K. Hussey, Susan T. Hall, Mick J. Daniel, Gary L. Evans, Karl H. Donn
Publikováno v:
The Journal of Clinical Pharmacology. 34:975-977
3TC is a dideoxy-nucleoside analogue that has demonstrated in-vitro activity against human immunodeficiency virus (HIV). 3TC concentrations in humans were predicted before the initiation of clinical trials by interspecies scaling of pharmacokinetic p